Media Contact:
Stephen Majors
Head of Global Communications
smajors@alliancerm.org
Washington, D.C.
The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization representing the cell and gene therapy sector, today formally announced that its Board of Directors has appointed Timothy D. Hunt as the organization’s next Chief Executive Officer.
Washington, DC
The Alliance for Regenerative Medicine (ARM) and the National Institute for Innovation in Manufacturing BioPharmaceuticals (NIIMBL) today released Project A-Cell, a multistakeholder collaboration to incorporate Quality by Design (QbD) principles into a manufacturing case study of a Chimeric Antigen Receptor T-cell (CAR-T) therapy.
Washington, DC
The European Commission’s proposed ‘Substances of Human Origin’ (SoHO) Regulation holds the promise of improving patient safety while establishing greater legal and regulatory certainty across the EU.
WASHINGTON, DC
Janet Lynch Lambert will step down as the CEO of the Alliance for Regenerative Medicine after guiding the leading international advocacy organization for cell, gene and tissue-engineered therapies through five years of extraordinary growth in membership, funding, and influence.
